More than half of Americans taking GLP-1s say it was difficult to afford
10.1111/dom.13129 72 NauckM.RizzoM.JohnsonA.Bosch-TrabergH.MadsenJ.CariouB
GLP1/GIP and the triple-agonist, promoting a sustained and significant decrease in body weight (8%), a marked reduction in fat tissue (40%) and food intake, as well as an improvement in glucose metabolism (Fig
However, an important shift is occurring in clinical practice: we are recognizing patients with socalled lean MASLD and questioning whether our traditional therapeutic frameworks adequately address the full spectrum of disease
My biggest concern with weight loss in a pill (or, in this case, an injection) is that people will no longer be hungry for the nutrients they need
These medications may support weight loss, improve insulin resistance, and even lead to Read More GLP1s for PCOS: From Insulin Resistance to Cycle Control Could a diabetes medication help women with PCOS regain control of their cycles and metabolism